Your browser doesn't support javascript.
loading
Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine Neoplasms.
Kaemmerer, Daniel; Twrznik, Matthias; Kulkarni, Harshad R; Hörsch, Dieter; Sehner, Susanne; Baum, Richard P; Hommann, Merten.
Afiliação
  • Kaemmerer D; Department of General and Visceral Surgery, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Twrznik M; Department of General and Visceral Surgery, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Kulkarni HR; Theranostics Center for Molecular Radiotherapy and Precision Oncology, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Hörsch D; Department of Gastroenterology/Endocrinology, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Sehner S; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Baum RP; Theranostics Center for Molecular Radiotherapy and Precision Oncology, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Hommann M; Department of General and Visceral Surgery, Zentralklinik Bad Berka, Bad Berka, Germany.
Ann Surg ; 274(1): e45-e53, 2021 07 01.
Article em En | MEDLINE | ID: mdl-33030849
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos / Radioisótopos de Ítrio / Tumores Neuroendócrinos / Compostos Radiofarmacêuticos / Lutécio Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos / Radioisótopos de Ítrio / Tumores Neuroendócrinos / Compostos Radiofarmacêuticos / Lutécio Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article